Pfizer and Flynn fined £90m for excessive pricing of epilepsy drug

The UK competition watchdog has fined two pharmaceutical companies £90m for charging what it has called excessive and unfair prices in the UK for phenytoin capsules. 
To read the whole article click on the headline